- Home
- CMP vs HUMA Comparison
CMP vs HUMA Comparison
Compare CMP & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMP
- HUMA
- Stock Information
- Founded
- CMP 1993
- HUMA 2004
- Country
- CMP United States
- HUMA United States
- Employees
- CMP N/A
- HUMA N/A
- Industry
- CMP Other Metals and Minerals
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- CMP Basic Materials
- HUMA Health Care
- Exchange
- CMP Nasdaq
- HUMA Nasdaq
- Market Cap
- CMP 493.5M
- HUMA 427.2M
- IPO Year
- CMP 2003
- HUMA N/A
- Fundamental
- Price
- CMP $9.12
- HUMA $1.49
- Analyst Decision
- CMP Buy
- HUMA Strong Buy
- Analyst Count
- CMP 3
- HUMA 6
- Target Price
- CMP $18.33
- HUMA $14.60
- AVG Volume (30 Days)
- CMP 519.4K
- HUMA 5.2M
- Earning Date
- CMP 05-06-2025
- HUMA 03-28-2025
- Dividend Yield
- CMP N/A
- HUMA N/A
- EPS Growth
- CMP N/A
- HUMA N/A
- EPS
- CMP N/A
- HUMA N/A
- Revenue
- CMP $1,082,900,000.00
- HUMA N/A
- Revenue This Year
- CMP $4.71
- HUMA N/A
- Revenue Next Year
- CMP $7.26
- HUMA $1,217.58
- P/E Ratio
- CMP N/A
- HUMA N/A
- Revenue Growth
- CMP N/A
- HUMA N/A
- 52 Week Low
- CMP $7.51
- HUMA $1.31
- 52 Week High
- CMP $15.82
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- CMP 34.12
- HUMA 22.36
- Support Level
- CMP $9.34
- HUMA $1.96
- Resistance Level
- CMP $9.91
- HUMA $3.36
- Average True Range (ATR)
- CMP 0.52
- HUMA 0.26
- MACD
- CMP -0.07
- HUMA -0.13
- Stochastic Oscillator
- CMP 5.57
- HUMA 8.74
About CMP Compass Minerals Intl Inc
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.